Mohammad Sameer Khan
About Mohammad Sameer Khan
Data last updated:
Mohammad Sameer Khan is a Director at Adem Life Sciences Private Limited (since 2021). The companies operate in Trading. Earlier, Mohammad Sameer Khan was a Director at Adem Pharma Private Limited (2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Adem Life Sciences Private Limited U51909UP2021PTC155578 | Director | 17 Nov 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Adem Pharma Private Limited U46497UP2024PTC201942 | Director | 30 Apr 2024 | 2024 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mohammad Sameer Khan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Afreen Fatima | 09402470 | Adem Life Sciences Private Limited | Director |
| Mohd Ali | 09402471 | Adem Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammad Sameer Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammad Sameer Khan
Mohammad Sameer Khan currently holds 1 directorship: Adem Life Sciences Private Limited (Director, since 17 Nov 2021).
Mohammad Sameer Khan was first appointed on 17 Nov 2021 as Director at Adem Life Sciences Private Limited. The most recent appointment on record is 30 Apr 2024 at Adem Pharma Private Limited.
Mohammad Sameer Khan held 1 earlier board appointment: Adem Pharma Private Limited (Director, 30 Apr 2024 to 30 Jun 2024).
The current boards of Mohammad Sameer Khan's companies include Afreen Fatima (Adem Life Sciences Private Limited), Mohd Ali (Adem Life Sciences Private Limited).